203 related articles for article (PubMed ID: 7602354)
1. Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study.
Schornagel JH; Verweij J; de Mulder PH; Cognetti F; Vermorken JB; Cappelaere P; Armand JP; Wildiers J; de Graeff A; Clavel M
J Clin Oncol; 1995 Jul; 13(7):1649-55. PubMed ID: 7602354
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative Group.
Schornagel JH; Verweij J; de Mulder PH; Cognetti F; Vermorken JB; Cappelaere P; Armand JP; Wildiers J; Clavel M; Kirkpatrick A
Ann Oncol; 1992 Mar; 3(3):223-6. PubMed ID: 1586620
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant methotrexate escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas--a prospective, randomized study.
Rentschler RE; Wilbur DW; Petti GH; Chonkich GD; Hilliard DA; Camacho ES; Thorpe RB
J Clin Oncol; 1987 Feb; 5(2):278-85. PubMed ID: 3806169
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of edatrexate in advanced head and neck cancer. A Southwest Oncology Group study.
Kuebler JP; Benedetti J; Schuller DE; Ensley J; Grunberg SM; Muirhead MJ; Richert-Boe KE; Marshall ME
Invest New Drugs; 1994; 12(4):341-4. PubMed ID: 7775138
[TBL] [Abstract][Full Text] [Related]
7. A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer.
Eisenberger M; Krasnow S; Ellenberg S; Silva H; Abrams J; Sinibaldi V; Van Echo D; Aisner J
J Clin Oncol; 1989 Sep; 7(9):1341-5. PubMed ID: 2671289
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate/fluorouracil scheduling influences normal tissue toxicity but not antitumor effects in patients with squamous cell head and neck cancer: results from a randomized trial.
Browman GP; Levine MN; Goodyear MD; Russell R; Archibald SD; Jackson BS; Young JE; Basrur V; Johanson C
J Clin Oncol; 1988 Jun; 6(6):963-8. PubMed ID: 3286831
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of edatrexate in advanced breast and other cancers.
Kuriakose P; Gandara DR; Perez EA
Cancer Invest; 2002; 20(4):473-9. PubMed ID: 12094542
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate and 5-fluorouracil in sequence in squamous head and neck cancer.
Pitman SW; Kowal CD; Bertino JR
Semin Oncol; 1983 Jun; 10(2 Suppl 2):15-9. PubMed ID: 6346497
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.
Gibson MK; Li Y; Murphy B; Hussain MH; DeConti RC; Ensley J; Forastiere AA;
J Clin Oncol; 2005 May; 23(15):3562-7. PubMed ID: 15908667
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial.
Browman GP; Goodyear MD; Levine MN; Russell R; Archibald SD; Young JE
J Clin Oncol; 1990 Feb; 8(2):203-8. PubMed ID: 2405105
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W
Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
[TBL] [Abstract][Full Text] [Related]
14. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
Sirotnak FM; Otter GM; Schmid FA
Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
[TBL] [Abstract][Full Text] [Related]
15. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck.
Hong WK; Schaefer S; Issell B; Cummings C; Luedke D; Bromer R; Fofonoff S; D'Aoust J; Shapshay S; Welch J; Levin E; Vincent M; Vaughan C; Strong S
Cancer; 1983 Jul; 52(2):206-10. PubMed ID: 6190545
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate treatment of advanced head and neck cancers: a dose response evaluation.
Woods RL; Fox RM; Tattersall MH
Cancer Treat Rep; 1981; 65 Suppl 1():155-9. PubMed ID: 7034929
[TBL] [Abstract][Full Text] [Related]
18. A new analogue of 10-deazaaminopterin with markedly enhanced curative effects against human tumor xenografts in mice.
Sirotnak FM; DeGraw JI; Colwell WT; Piper JR
Cancer Chemother Pharmacol; 1998; 42(4):313-8. PubMed ID: 9744777
[TBL] [Abstract][Full Text] [Related]
19. Schedule-dependent edatrexate toxicity.
Perez EA
J Clin Oncol; 1996 Jan; 14(1):322-3. PubMed ID: 8558215
[No Abstract] [Full Text] [Related]
20. Sequential methotrexate, 5-fluorouracil, and cisplatin in the treatment of recurrent squamous-cell carcinoma of the head and neck: failure of hypertonic saline to reduce the nephrotoxicity of cisplatin.
Dimery IW; Legha SS
J Clin Oncol; 1986 Nov; 4(11):1670-6. PubMed ID: 3095503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
